InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: Jonjones325 post# 82174

Tuesday, 12/06/2016 8:10:37 AM

Tuesday, December 06, 2016 8:10:37 AM

Post# of 463684
clinicaltrials.gov current version of the trial says the secondary objective is, "...to explore the relationship of ANAVEX2-73 as add-on therapy to AD standard of care." That does not imply all the patients have been moved onto monotherapy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News